John Martinez - Bioelectronics Corp Senior Engineer

BIEL Stock  USD 0.0003  0.0001  50.00%   

Executive

Mr. John M. Martinez is Senior Engineer of BioElectronics Corporationrationration, since April 2002. Mr. Martinez holds a Bachelors of Applied Science degree in Electronics Engineering Technology from ITT Technical Institute where he graduated with highest honors, and has worked exclusively in the electronicsengineering field for over ten years. His dedication and experience in multiple fields of engineering, including electronic, electromechanical, computer and communication systems, represent the foundation of his engineering talents. Mr. Martinez was the cofounder of MW Engineering, Inc., where he served as Senior Engineering Director from 1999 until April 2002. As Senior Engineering Director, Mr. Martinez was in charge of all of MW Engineerings hardware, firmware and software development. since 2002.
Tenure 22 years
Phone301 874 4890
Webhttps://www.bielcorp.com

John Martinez Latest Insider Activity

Tracking and analyzing the buying and selling activities of John Martinez against Bioelectronics Corp pink sheet is an integral part of due diligence when investing in Bioelectronics Corp. John Martinez insider activity provides valuable insight into whether Bioelectronics Corp is net buyers or sellers over its current business cycle. Note, Bioelectronics Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bioelectronics Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Bioelectronics Corp Management Efficiency

The company has return on total asset (ROA) of (0.3367) % which means that it has lost $0.3367 on every $100 spent on assets. This is way below average. Bioelectronics Corp's management efficiency ratios could be used to measure how well Bioelectronics Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange. Bioelectronics Corp [BIEL] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Bioelectronics Corp Leadership Team

Elected by the shareholders, the Bioelectronics Corp's board of directors comprises two types of representatives: Bioelectronics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioelectronics. The board's role is to monitor Bioelectronics Corp's management team and ensure that shareholders' interests are well served. Bioelectronics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioelectronics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kelly Whelan, President, CEO
Keith Nalepka, VP Director
John Martinez, Senior Engineer
Andrew Whelan, CEO and President Founder, CFO and Director

Bioelectronics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bioelectronics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.